Publications by authors named "Gerald Cruciani"

Claim this Profile
P
Parkinson's Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2-Hydroxypropyl-β-Cyclodextrin Treatment.
Javier Jarazo, Kyriaki Barmpa, Jennifer Modamio, Cláudia Saraiva, Sònia Sabaté-Soler, Gerald Cruciani

Mov Disord· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function.
Peter A Barbuti, Jochen Ohnmacht, Bruno F R Santos, Paul M Antony, François Massart, Gérald Cruciani

Sci Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated, automated maintenance, expansion and differentiation of 2D and 3D patient-derived cellular models for high throughput drug screening.
Ibrahim Boussaad, Gérald Cruciani, Silvia Bolognin, Paul Antony, Claire M Dording

Sci Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of two iPS cell lines (HIHDNDi001-A and HIHDNDi001-B) from a Parkinson's disease patient carrying the heterozygous p.A30P mutation in SNCA.
Peter A Barbuti, Bruno F R Santos, Claire M Dording, Gérald Cruciani, François Massart

Stem Cell Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A patient-based model of RNA mis-splicing uncovers treatment targets in Parkinson's disease.
Ibrahim Boussaad, Carolin D Obermaier, Zoé Hanss, Dheeraj R Bobbili, Silvia Bolognin, Gérald Cruciani

Sci Transl Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using High-Content Screening to Generate Single-Cell Gene-Corrected Patient-Derived iPS Clones Reveals Excess Alpha-Synuclein with Familial Parkinson's Disease Point Mutation A30P.
Peter Barbuti, Paul Antony, Bruno Santos, François Massart, Gérald Cruciani

Cells· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induced pluripotent stem cell line (LCSBi001-A) derived from a patient with Parkinson's disease carrying the p.D620N mutation in VPS35.
Simone B Larsen, Zoé Hanss, Gérald Cruciani, François Massart, Peter A Barbuti

Stem Cell Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis